Literature DB >> 27665086

A cluster analysis of early onset in common anxiety disorders.

A Schat1, M S van Noorden2, M J Noom3, E J Giltay2, N J A van der Wee2, R de Graaf4, M Ten Have4, R R J M M Vermeiren5, F G Zitman2.   

Abstract

Early onset is regarded as an important characteristic of anxiety disorders, associated with higher severity. However, previous findings diverge, as definitions of early onset vary and are often unsubstantiated. We objectively defined early onset in social phobia, panic disorder, agoraphobia, and generalised anxiety disorder, using cluster analysis with data gathered in the general population. Resulting cut-off ages for early onset were ≤22 (social phobia), ≤31 (panic disorder), ≤21 (agoraphobia), and ≤27 (generalised anxiety disorder). Comparison of psychiatric comorbidity and general wellbeing between subjects with early and late onset in the general population and an outpatient cohort, demonstrated that among outpatients anxiety comorbidity was more common in early onset agoraphobia, but also that anxiety- as well as mood comorbidity were more common in late onset social phobia. A major limitation was the retrospective assessment of onset. Our results encourage future studies into correlates of early onset of psychiatric disorders.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Age of onset; Anxiety disorders; Cluster analysis; General population; Naturalistic; Outpatient

Mesh:

Year:  2016        PMID: 27665086     DOI: 10.1016/j.janxdis.2016.09.001

Source DB:  PubMed          Journal:  J Anxiety Disord        ISSN: 0887-6185


  1 in total

1.  Early age of onset of mood, anxiety and alcohol use disorders is associated with sociodemographic characteristics and health outcomes in adults: results from a cross-sectional national survey.

Authors:  Janhavi Ajit Vaingankar; Siow Ann Chong; Edimansyah Abdin; Saleha Shafie; Boon Yiang Chua; Shazana Shahwan; Swapna Verma; Mythily Subramaniam
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2021-03-31       Impact factor: 4.328

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.